Table 2.
Patient’s baseline clinical characteristics, N = 105
| Parameters/characteristics | n (%) |
|---|---|
| Duration of T2DM (years)a | 11.5 ± 8.5 |
| ≤ 10 | 53 (50.5) |
| 11–20 | 39 (37.1) |
| 21–30 | 8 (7.6) |
| > 30 | 5 (4.8) |
| Comorbidities | |
| Hypertension | 74 (70.5) |
| Dyslipidaemia | 50 (47.6) |
| Ischaemic heart disease | 12 (11.4) |
| Cerebrovascular accident | 2 (1.9) |
| Renal impairment | 13 (12.4) |
| Liver impairment | 9 (8.6) |
| Heart failure | 5 (4.8) |
| Diabetic complications | |
| Neuropathy | 9 (8.6) |
| Nephropathy | 5 (4.8) |
| Retinopathy | 12 (11.4) |
| All of the above | 2 (1.9) |
| HbA1c (%)a | 8.5 ± 1.8 |
| < 6.5 | 8 (7.6) |
| 6.5–9.9 | 76 (72.4) |
| ≥ 10 | 21 (20.0) |
| FBG (mmol/L)a | 9.1 ± 3.8 |
| ALT (μmol/L)a | 31.0 ± 0.2 |
| TC (mmol/L)a | 5.0 ± 4.0 |
| TG (mmol/L)a | 1.9 ± 1.3 |
| LDL (mmol/L)a | 2.6 ± 0.9 |
| HDL (mmol/L)a | 1.2 ± 0.4 |
aContinuous variable reported as mean ± SD